Analogous to IFN-β-Treated MS Patients, Patients with Depression, Systemic Lupus Erythematosus or Parkinson’s Disease are Characterized by Increased Plasma Ceramides. The gene discussed is IFNB1; the disease is systemic lupus erythematosus.